{
    "eid": "2-s2.0-85142438590",
    "title": "DEK::AFF2 Fusion Carcinomas of Head and Neck",
    "cover-date": "2023-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Anatomy",
            "@code": "2702",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pathology and Forensic Medicine",
            "@code": "2734",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "AFF2",
        "DEK",
        "DEK::AFF2",
        "middle ear",
        "nonkeratinizing",
        "sinonasal",
        "squamous cell carcinoma",
        "temporal bone"
    ],
    "authors": [
        "Komkrit Ruangritchankul",
        "Ann Sandison"
    ],
    "citedby-count": 5,
    "ref-count": 53,
    "ref-list": [
        "Rare cancers of the head and neck area in Europe",
        "Sinonasal malignancies: a population-based analysis of site-specific incidence and survival",
        "Sinonasal cancer in the Italian national surveillance system: epidemiology, occupation, and public health implications",
        "Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Nasal Cavity, Paranasal Sinuses and Skull Base",
        "Immunogenic neoantigens derived from gene fusions stimulate T cell responses",
        "Middle ear and temporal bone nonkeratinizing squamous cell carcinomas with DEK::AFF 2 fusion: an emerging entity",
        "Nonkeratinizing squamous cell carcinoma of the sinonasal tract with DEK::AFF 2: further solidifying an emerging entity",
        "DEK::AFF 2 carcinoma of the sinonasal region and skull base: detailed clinicopathologic characterization of a distinctive entity",
        "DEK::AFF 2 fusion-associated papillary squamous cell carcinoma of the sinonasal tract: clinicopathologic characterization of seven cases with deceptively bland morphology",
        "Nuclear expression of AFF2 C-terminus is a sensitive and specific ancillary marker for DEK::AFF2 carcinoma of the sinonasal tract",
        "Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma",
        "NUT midline carcinomas of the sinonasal tract",
        "HPV-related multiphenotypic sinonasal carcinoma: an expanded series of 49 cases of the tumor formerly known as HPV-related carcinoma with adenoid cystic carcinoma-like features",
        "SMARCB1 (INI-1)-deficient sinonasal carcinoma: a series of 39 cases expanding the morphologic and clinicopathologic spectrum of a recently described entity",
        "SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms",
        "SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract",
        "OSPs and ESPs and ISPs, Oh My! an update on sinonasal (Schneiderian) papillomas",
        "SMARCA4-deficient sinonasal carcinoma: a series of 10 cases expanding the genetic spectrum of SWI/SNF-driven sinonasal malignancies",
        "Soft tissue special issue: adamantinoma-like Ewing sarcoma of the head and neck: a practical review of a challenging emerging entity",
        "Adamantinoma-like Ewing family tumors of the head and neck: a pitfall in the differential diagnosis of basaloid and myoepithelial carcinomas",
        "Low-grade papillary Schneiderian carcinoma, a unique and deceptively bland malignant neoplasm: report of a case",
        "Low-grade papillary Schneiderian carcinoma: a case report",
        "Low-grade papillary Schneiderian carcinoma of the sinonasal cavity and temporal bone",
        "Low-grade papillary Schneiderian carcinoma; rare or under-recognised?",
        "Clinicopathological analysis of low-grade papillary Schneiderian carcinoma: report of five new cases and review of the literature",
        "Low-grade papillary Schneiderian carcinoma: report of a case with molecular characterization",
        "The DEK protein-an abundant and ubiquitous constituent of mammalian chromatin",
        "The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity",
        "The human DEK oncogene stimulates \u03b2-catenin signaling, invasion and mammosphere formation in breast cancer",
        "Melanoma proliferation and chemoresistance controlled by the DEK oncogene",
        "DEK Expression is controlled by E2F and deregulated in diverse tumor types",
        "Characterization of the translocation breakpoint sequences of two DEK-CAN fusion genes present in t(6;9) acute myeloid leukemia and a SET-CAN fusion gene found in a case of acute undifferentiated leukemia",
        "The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA",
        "DEK-NUP214-fusion identified by RNA-sequencing of an acute myeloid leukemia with t(9;12)(q34;q15)",
        "Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma",
        "Expression analysis of 6p22 genomic gain in retinoblastoma",
        "Novel 6p rearrangements and recurrent translocation breakpoints in retinoblastoma cell lines identified by spectral karyotyping and mBAND analyses",
        "The identification of novel therapeutic targets for the treatment of malignant brain tumors",
        "Expression and significance of tumor-related genes in HCC",
        "DEK promotes HPV-positive and -negative head and neck cancer cell proliferation",
        "DEK oncoprotein regulates transcriptional modifiers and sustains tumor initiation activity in high-grade neuroendocrine carcinoma of the lung",
        "Concise review: role of DEK in stem/progenitor cell biology",
        "Functional characterization of the AFF (AF4/FMR2) family of RNA-binding proteins: insights into the molecular pathology of FRAXE intellectual disability",
        "Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice",
        "Identification of the gene FMR2, associated with FRAXE mental retardation",
        "Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island",
        "A candidate gene for mild mental handicap at the FRAXE fragile site",
        "Japan Children's Cancer Study Group (JCCG). Characteristics of genetic alterations of peripheral T-cell lymphoma in childhood including identification of novel fusion genes: the Japan Children's Cancer Group (JCCG)",
        "Unclassified neuroendocrine tumor with a novel CHD4-AFF2 fusion: expanding the family of AFF2-rearranged head and neck malignancies",
        "Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions",
        "A novel LARGE1-AFF2 fusion expanding the molecular alterations associated with the methylation class of neuroepithelial tumors with PATZ1 fusions",
        "A novel WWTR1-AFF2 fusion in an intra-abdominal soft tissue sarcoma with associated endometriosis"
    ],
    "affiliation": [
        {
            "affiliation-city": "London",
            "@id": "60005518",
            "affilname": "Guy's and St Thomas' NHS Foundation Trust",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005518",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}